In a major escalation of the patent battle over a life-saving rare disease drug, Swiss pharmaceutical giant F. Hoffmann-La ...

As more people start to opt for genetic carrier testing ahead of conception, doctors and parents-to-be are facing difficult ...

Gene therapy is linked to better nonmotor outcomes in spinal muscular atrophy type 1 compared to first-line nusinersen, new ...

For people with spinal muscular atrophy, physical therapy can help support mobility, strength, and quality of life, regardless of SMA type.

Columnist Helen Baldwin worried the baby who arrived May 18, 1997, would keep everyone awake, but his silence signaled a ...

Roche approached the Supreme Court after the Delhi High Court division bench refused to bar Natco Pharma from selling the ...

Roche has moved the Supreme Court challenging a Delhi HC order that allowed Natco Pharma to manufacture and sell a generic ...

Shares in US biopharma Scholar Rock closed 13% lower Monday after bad news on its spinal muscular atrophy (SMA) treatment ...

F. Hoffmann-La Roche AG has approached the Supreme Court. This follows a Delhi High Court decision permitting Natco Pharma to ...

Swiss pharmaceutical giant F Hoffmann-La Roche AG has approached the Supreme Court against the Delhi High Court's order allowing Natco Pharma to manufacture and sell a generic drug of Risdiplam, ...

In what is being termed a major victory, Natco Pharma has won a legal battle against Swiss pharma giant Roche, allowing the ...

Swiss drugmaker Roche has sought the Supreme Court's intervention to prevent Natco Pharma from selling a generic version of its spinal muscular atrophy drug, Risdiplam, in India.